Elutia Inc

NASDAQ:ELUTUnited States

Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Device Protection, Women’s Health and Cardiovascular markets. These products are primarily sold to healthcare providers or commercial partners. In Device Protection, it sells CanGaroo, a biological envelope, that is indicated for use with implantable electronic devices, including cardiac and neurostimulator devices. In Women’s Health, it has developed both patented and proprietary technologies, culminating in the creation of SimpliDerm, a biological matrix designed to leverage the inherent science of natural healing processes. In Cardiovascular, it sells its specialized porcine small intestine submucosa, which is also the tissue used to make CanGaroo, for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population.

Contact Information

Headquarters

12510 PROSPERITY DRIVE, SUITE 370SILVER SPRING, MD, United States 20904

Phone

240-247-1143

Fax

510-307-9896

Executives

Lead Independent Chairman of the Board

Kevin Rakin

President, Chief Executive Officer, Director

C. Randal Mills

Chief Financial Officer

Matthew Ferguson

Chief Scientific Officer

Michelle Williams

Independent Director

David Colpman